23andMe Holding Co (ME)
4.05
+0.09
(+2.27%)
USD |
NASDAQ |
Jan 08, 16:00
4.00
-0.05
(-1.23%)
Pre-Market: 08:15
23andMe Research and Development Expense (Quarterly): 41.04M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
RadNet Inc | -- |
iSpecimen Inc | 0.7547M |
Natera Inc | 96.93M |
Progyny Inc | -- |
Delcath Systems Inc | 3.866M |